| Name | Marcs |
|---|---|
| Organization Name | Marc Glassman Inc |
| Location | 3112 Cleveland Ave Nw, Canton, Ohio 44709 |
| Type | Pharmacy |
| Phone | (330) 492-2963 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
On Election Day, voters in the Bay State will consider whether to approve the "Death With Dignity Act," a measure that would make Massachusetts just the third state in the country to formally approve physician-assisted suicide. The proposal, identified as Question 2 on the ballot, is nearly identical to laws passed in Oregon in 1994 and in Washington in 2008. But the politics is very different. The looming vote has split the state's medical community and mobilized opposition from the politically powerful Catholic Church.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
Raman spectroscopy has enabled incredible advances in numerous scientific fields and is a powerful tool for tissue classification and disease recognition, although there have been considerable challenges to using the method in a clinical setting. Scientists have now demonstrated the advantages of wavelength-modulated Raman spectroscopy, opening the door to wider biomedical and clinical applications such as real-time assessment of tissues during surgery.
Canadian Breast Cancer Foundation funded research will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
› Verified 8 days ago
| NPI Number | 1578578415 |
| Organization Name | MARC GLASSMAN INC |
| Doing Business As | MARCS |
| Type | Pharmacy |
| Address | 3112 Cleveland Ave Nw, Canton, OH 44709 |
| Phone Number | 330-492-2963 |
News Archive
On Election Day, voters in the Bay State will consider whether to approve the "Death With Dignity Act," a measure that would make Massachusetts just the third state in the country to formally approve physician-assisted suicide. The proposal, identified as Question 2 on the ballot, is nearly identical to laws passed in Oregon in 1994 and in Washington in 2008. But the politics is very different. The looming vote has split the state's medical community and mobilized opposition from the politically powerful Catholic Church.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
Raman spectroscopy has enabled incredible advances in numerous scientific fields and is a powerful tool for tissue classification and disease recognition, although there have been considerable challenges to using the method in a clinical setting. Scientists have now demonstrated the advantages of wavelength-modulated Raman spectroscopy, opening the door to wider biomedical and clinical applications such as real-time assessment of tissues during surgery.
Canadian Breast Cancer Foundation funded research will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
› Verified 8 days ago
News Archive
On Election Day, voters in the Bay State will consider whether to approve the "Death With Dignity Act," a measure that would make Massachusetts just the third state in the country to formally approve physician-assisted suicide. The proposal, identified as Question 2 on the ballot, is nearly identical to laws passed in Oregon in 1994 and in Washington in 2008. But the politics is very different. The looming vote has split the state's medical community and mobilized opposition from the politically powerful Catholic Church.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
Raman spectroscopy has enabled incredible advances in numerous scientific fields and is a powerful tool for tissue classification and disease recognition, although there have been considerable challenges to using the method in a clinical setting. Scientists have now demonstrated the advantages of wavelength-modulated Raman spectroscopy, opening the door to wider biomedical and clinical applications such as real-time assessment of tissues during surgery.
Canadian Breast Cancer Foundation funded research will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
› Verified 8 days ago
Giant Eagle Pharmacy #4387 Type: Pharmacy Location: 3100 Cromer Ave, Canton, Ohio 44709 Phone: (330) 493-9404 | |
Giant Eagle Pharmacy 4034 Type: Pharmacy Location: 608 Raff Rd Sw, Canton, Ohio 44710 Phone: (330) 452-5905 | |
Millers Rental And Sales Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4705 Tuscarawas St W, Canton, Ohio 44708 Phone: (330) 478-4100 | |
Rite Aid Pharmacy 02415 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3010 Whipple Ave Nw, Canton, Ohio 44718 Phone: (330) 477-7269 | |
Rite Aid Pharmacy 03061 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4332 Cleveland Ave Nw, Canton, Ohio 44709 Phone: (330) 649-9709 |